Publikationen 2017
T. Heimburg, F. R. Kolbinger, P. Zeyen, E. Ghazy, D. Herp, K. Schmidtkunz, J. Melesina, T. B. Shaik, F. Erdmann, M. Schmidt, C. Romier, D. Robaa, O. Witt, I. Oehme, M. Jung, and W. Sippl. Structure-based design and biological characterization of selective HDAC8 inhibitors with anti-neuroblastoma activity. J. Med. Chem. 60, 10188-10204, 2017. DOI:10.1021/acs.jmedchem.7b01447
M. Schmidt , A. Rohe, C. Platzer, A. Najjar, F. Erdmann, and W. Sippl. Regulation of G2/M transition by inhibition of WEE1 and PKMYT1 kinases. Molecules, 22(12), pii: E2045, 2017. doi:10.3390/molecules22122045
M. Wünsch, J. Senger, P. Schultheisz, S. Schwarzbich, K. Schmidtkunz, C. Michalek, M. Klaß, S. Goskowitz ,P. Borchert , L. Praetorius, W. Sippl, M. Jung, N. Sewald. Structure-Activity Relationship of Propargylamine-Based HDAC Inhibitors. ChemMedChem. 12, 2044-2053, 2017. doi:10.1002/cmdc.201700550 .
S. Gawaskar, L. Temme, J. A. Schreiber, D. Schepmann, A. Bonifazi, D. Robaa, W. Sippl, N. Strutz-Seebohm, G. Seebohm, B. Wünsch. Design, synthesis, pharmacological evaluation and docking studies of novel GluN2B selective NMDA receptor antagonists with benzo[7]annulen-7-amine scaffold. ChemMedChem 12, 1212-1222, 2017. doi:10.1002/cmdc.201700311
F. Ntie-Kang, K. K. Telukunt, K. Döring, C. V. Simoben, A. F. A. Moumbock, Y. I. Malange, L. E. Njume, J. N. Yong, W. Sippl, and S. Günther. NANPDB: A Resource for Natural Products from Northern African Sources. J. Nat. Prod. 80, 2067-2076, 2017. DOI:10.1021/acs.jnatprod.7b00283 .
A. F.A. Moumbock, C. V. Simoben, L. Wessjohann, W. Sippl, S. Günther and F. Ntie‐Kang. Computational Studies and Biosynthesis of Natural Products with Promising Anticancer Properties. In: Medicine - Natural Products and Cancer Drug Discovery. Ed. Farid A. BadriaIntech: ISBN 978-953-51-3314-8, Print ISBN 978-953-51-3313-1. 2017
K. Stenzel, A. Chakrabarti, J. Melesina, F. K. Hansen, J. Lancelot, S. Herkenhöhner, B. Lungerich, M. Marek, C. Romier, R. J. Pierce, W. Sippl, M. Jung, T. Kurz. Alkoxyamide-based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni. Arch Pharm (Weinheim), 350(8), 2017.doi:10.1002/ardp.201700097 .
D. Wutz, D. Gluhacevic, A. Chakrabarti, K. Schmidtkunz, D. Robaa, F. Erdmann, C. Romier, W. Sippl, M. Jung, B. König. Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides. Org Biomol Chem. 15, 4882-4896, 2017. doi:10.1039/c7ob00976c.
Moumbock, A. F. A.; Simoben, C. V.; Wessjohann, L.; Sippl, W.; Günther, S.; Ntie-Kang, F. Computational studies and biosynthesis of natural products with promising anticancer properties. In Phytochemistry - Natural Products and Cancer. Badria, F. A. (Editor). InTech: ISBN 978-953-51-5277-4. 2017
A. Najjar, F. Ntie-Kang, W. Sippl. Application of computer modeling to anticancer natural products drug discovery. In Unique Aspects of Anti-cancer Drug Development. Latosińska, J.; Latosińska, M. (Editors); InTech: ISBN 978-953-51-5240-8. 2017
L. L. S. Scholte, M. M. Mourãa, F. Sviatopolk-Mirsky Paisa, J. Melesina, D. Robaa, A. C. Volpini, W. Sippl, R. J. Piercee, G. Oliveira, L. A. Nahum. Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases, Infect Genet Evol. 53:175-188, 2017. doi:10.1016/j.meegid.2017.05.011 .
T. Fischer, T. Krüger, A. Najjar, F. Totzke, C. Schächtele, W. Sippl, C. Ritter, A. Hilgeroth. Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors. Bioorg Med Chem Lett. 27, 2708-2712, 2017. doi:10.1016/j.bmcl.2017.04.053.
S. Vojacek, K. Beese, Z. Al Halabi, S. Swyter, A. Bodtke, C. Schulzke, M. Jung, W. Sippl, and A. Link. Three-Component Aminoalkylations Yielding Dihydronaphthoxazine-Based Sirtuin Inhibitors: Scaffold Modification and Exploration of Space for Polar Side-Chains. Arch Pharm (Weinheim), 350(7), 2017. doi:10.1002/ardp.201700097 .
G. S. Hailu, D. Robaa, M. Forgione, M.W. Sippl, D. Rotili, A. Mai. Potential of Histone Deacetylase Inhibitors as Anti-Parasitic Agents. J. Med. Chem. 60, 4780-4804, 2017. doi:10.1021/acs.jmedchem.6b01595 .
E. E. Gurdal, B. Turgutalp, H. O. Gulcan, T. Erçetin, M. F. Sahin, I. Durmaz. R. C. Atalay, Q. D. Nguyen, W. Sippl. M. Yarim. Synthesis of Novel Benzothiazole-Piperazine Derivatives and Their Biological Evaluation as Acetylcholinesterase Inhibitors and Cytotoxic Agents. Anticancer Agents Med Chem.17(13):1837-1845, 2017. doi:10.2174/1871520617666170412153604.
M. Schiedel, A. Fallarero, C. Luise, W. Sippl, P. Vuorela, and M. Jung. Synthesis and biological evaluation of 8-hydroxy-2,7-naphthyridinium salts as potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Med. Chem. Comm. 8, 465-470, 2017. DOI:10.1039/C6MD00647G
C. Hempel, F. Totzke, C. Schaechtele, A. Najjar, W. Sippl, C. Ritter, A. Hilgeroth. Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R. J. Enzyme Inhib. Med. Chem. 32, 271–276, 2017. doi:10.1080/14756366.2016.1247062 .
B. Sauer, T. S. Skinner-Adams, A. Bouchut, M. J. Chua, C. Pierrot, F. Erdmann, D. Robaa, M. Schmidt, J. Khalife, K. T. Andrews, W. Sippl Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum. Eur. J. Med. Chem. 127, 22-40, 2017. doi:10.1016/j.ejmech.2016.12.041.
F. Erdmann, W. Lin, C. Platzer, M Schmidt, W. Sippl, G. Fischer, Y. Zhang. Augmented Reversible Photoswitching of Drug-Target Interaction through "Surface Borrowing". Biochem Pharmacol.125, 84-92, 2017. doi:10.1016/j.bcp.2016.11.011
D.Lehmann, L. Motlagh, D. Robaa, S. Zierz. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features. Int. J. Mol. Sci.18, pii: E82, 2017. doi:10.3390/ijms18010082